OTTAWA, Nov. 1 /CNW/ - Liponex Inc. (TSX:LPX), a biopharmaceutical company specializing in developing advanced products related to High Density Lipoprotein (HDL), often called “good cholesterol,” today announced its financial results for the third quarter ended September 30, 2006.
